Intellia Therapeutics, Inc. Financial Ratios — NTLA Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-26.71	-16.6	-20.01	-23.59	-29.21	-26.56	-27.19	-33.69	-34.11	-41.66	-40.6
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	-216.43	-188.45	-254.86	-283.91	-233.81	-224.63	-789.52	-864.51	-1,395.77	-905.33	-628.14
Operating Margin (%)	- -	-221.86	-195.15	-266.32	-298.58	-246.78	-235.51	-810.37	-879.04	-1,420.51	-923.1	-651.67
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-221.86	-191.97	-258.62	-280.42	-230.92	-231.46	-810.49	-909.78	-1,326.51	-896.77	-609.85
Profit Margin (%)	- -	-205.11	-191.97	-258.62	-280.42	-230.92	-231.46	-810.49	-909.78	-1,326.51	-896.77	-609.85
Net Income to Common Margin (%)	- -	-205.11	-191.97	-258.62	-280.42	-230.92	-231.46	-810.49	-909.78	-1,326.51	-896.77	-609.85
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	18	39	74	131	115	210	93
ST Debt	- -	- -	- -	- -	- -	6	6	9	17	19	20	26
LT Debt	- -	- -	- -	- -	- -	13	34	65	114	97	190	67
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.18	-0.3	-0.28	-0.29	-0.23	-0.4	-0.22
Net Debt/EBITDA	- -	5.8	8.79	5.12	0.68	0.57	1.23	0.47	1.16	0.45	0.36	0.37
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.17	-0.29	-0.28	-0.29	-0.22	-0.39	-0.21
Net Debt/EBIT	- -	5.65	8.49	4.9	0.65	0.54	1.17	0.46	1.14	0.44	0.35	0.35
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-83.06	-26.71	-17.92	-32.19	-57.88	-90.01	-64.33	-54.31	-77.44	-127.47	-182.82	-307.56
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	4.68	6.38	6.24	9.23	9.21	21.78	9.96
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-4.47	-8.49	-10.32	-10.9	-6.27	-9.66	-2.68
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	3.78	4.97	5.01	7.5	7.44	15.95	7.94
Total Debt/Equity (%)	- -	- -	- -	- -	- -	6.81	7.46	7.12	10.58	10.98	24.11	13.9
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-6.5	-9.93	-11.77	-12.49	-7.48	-10.69	-3.74
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	5.5	5.81	5.72	8.6	8.87	17.65	11.08
Net Debt to Equity	-130.12	357.61	-130.13	-113.33	-21.18	-21.2	-30.36	-11.86	-42.37	-21.59	-21.7	-23.16
Net Debt/Capital (%)	431.99	77.56	83.6	73.77	22.65	16.84	28.79	16.4	33.34	12.81	8.77	5.86
EBITDA	- -	-13	-31	-67	-86	-101	-130	-261	-451	-506	-524	-425
EBITDA-CapEx	- -	-16	-37	-77	-93	-108	-134	-274	-509	-520	-530	-426
Operating Income (Loss)	- -	-13	-32	-70	-91	-106	-137	-268	-458	-515	-534	-441

Liquidity (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.18	7.09	8.89	10.86	7.74	7.85	9.3	5.95	9.42	7.92	5.43	4.33
Current Ratio	4.3	7.26	9.15	11.32	8.01	8.12	9.59	6.11	9.61	8.67	5.77	5.08
Quick Ratio	4.18	7.18	9.1	11.2	7.93	7.98	9.33	5.97	9.45	8.23	5.5	4.42
CFO/Avg Current Liab	- -	-0.27	1.74	-2.1	-1.7	-2.71	-1	-2.37	-2.64	-3.26	-3.09	-3.68
Common Equity/Total Assets	-83.06	-26.71	-17.92	-32.19	-57.88	-90.01	-64.33	-54.31	-77.44	-127.47	-182.82	-307.56
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	4.68	6.38	6.24	9.23	9.21	21.78	9.96
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-4.47	-8.49	-10.32	-10.9	-6.27	-9.66	-2.68
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	3.78	4.97	5.01	7.5	7.44	15.95	7.94
Total Debt/Equity (%)	- -	- -	- -	- -	- -	6.81	7.46	7.12	10.58	10.98	24.11	13.9
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-6.5	-9.93	-11.77	-12.49	-7.48	-10.69	-3.74
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	5.5	5.81	5.72	8.6	8.87	17.65	11.08
CFO/Total Liabilities	- -	-1.71	40.51	-86.3	-88.27	-160.31	-33.44	-88.52	-117.14	-157.13	-109.35	-231.2
CFO/CapEx	- -	-0.69	5.86	-6.47	-9.63	-15.2	-13.92	-17.64	-5.71	-28.18	-60.38	-349.63
Altman's Z-Score	-0.38	0.14	2.42	5.53	4.48	5.19	11.74	18.96	4.48	4.23	-1.29	-1.93

Working Capital (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	12.09	4.42	3.09	3.38	7.09	17.18	15.89	17.98	1.8	2.57	7.53
Days Sales Outstanding	- -	30.2	82.55	118.27	108.05	51.52	21.24	22.97	20.31	202.37	141.81	48.5
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	291	692	588	693	3,046	8,383	2,686	2,707	1,153	974
- Cash & Cash Equivalents	10	76	273	341	59	57	160	123	524	227	189	155
+ Preferred Equity and Hybrid Capital	16	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	18	39	74	131	115	210	93
Enterprise Value	7	-76	18	351	274	432	2,488	7,708	1,624	1,910	761	618
Total Capital	8	-22	-54	-121	-201	-282	-396	-629	-1,046	-1,543	-1,967	-2,497
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-6.5	-9.93	-11.77	-12.49	-7.48	-10.69	-3.74
Total Debt / EV	- -	- -	- -	- -	- -	0.04	0.02	0.01	0.08	0.06	0.28	0.15
EV/Sales	- -	- -	1.11	13.45	9	10.02	42.89	233.2	31.15	52.65	13.15	9.13
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	0.51	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	0.43	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	291	692	588	693	3,046	8,383	2,686	2,707	1,153	974
Diluted Enterprise Value	7	-76	18	351	529	654	2,925	8,333	2,293	2,595	1,174	912
EV per Share	- -	- -	0.82	9.76	6.36	9.14	44.43	108.72	21.09	21.51	7.7	5.7
TTM Sales	- -	6	16	26	30	43	58	33	52	36	58	68
TTM EBITDA	- -	-13	-31	-67	-86	-101	-130	-261	-451	-506	-524	-425
TTM Operating Income	- -	-13	-32	-70	-91	-106	-137	-268	-458	-515	-534	-441
TTM Cash Flow to Firm	- -	-2	36	-65	-61	-103	-50	-225	-333	-394	-349	-395
TTM Free Cash Flow to Firm	- -	1	42	-55	-55	-96	-46	-212	-275	-380	-343	-394

Multiples (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	6.89	-12.54	-10.71	-7.19	-65.74	-39.49	-9.77	-7.12	-3.36	-2.48
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	7	-76	18	351	274	432	2,488	7,708	1,624	1,910	761	618
Low Price	- -	- -	11.86	10.83	11.03	10.26	9.18	43.86	32.72	22.66	11.34	5.9
EV/Sales	- -	- -	1.11	13.45	9	10.02	42.89	233.2	31.15	52.65	13.15	9.13
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-13.64	-9.25	-12.17	-7.18	-9.17	-28.05	-9.94	-6.79	-4.28	-2.92
Price/Earnings High	- -	- -	-21.36	-17.77	-18.16	-9.02	-29.2	-53.65	-19.42	-8.76	-6.64	-7.42
Price/Earnings Low	- -	- -	-8.33	-5.77	-5.57	-4.87	-3.83	-11.61	-5.31	-4.18	-2.16	-1.55
Price/Book Value	- -	- -	-5.44	-5.71	-2.92	-2.3	-7	-11.92	-2.28	-1.63	-0.53	-0.38
Price/Book Value Average	- -	- -	-8.05	-5.16	-5.17	-2.37	-2.83	-10.69	-4	-1.97	-1.02	-0.47
Price/Book Value High	- -	- -	-12.61	-9.91	-7.71	-2.98	-9.01	-20.44	-7.82	-2.54	-1.58	-1.18
Price/Book Value Low	- -	- -	-4.92	-3.22	-2.36	-1.61	-1.18	-4.42	-2.14	-1.21	-0.51	-0.25
Price/Tangible Book Value	- -	- -	1.39	2.3	2.12	2.57	5.78	8.06	2.17	2.58	1.32	1.45
Price/Tangible Book Value Average	- -	- -	2.06	2.08	3.74	2.65	2.34	7.22	3.81	3.11	2.55	1.8
Price/Tangible Book Value High	- -	- -	3.22	3.99	5.58	3.33	7.44	13.82	7.45	4.01	3.95	4.56
Price/Tangible Book Value Low	- -	- -	1.26	1.3	1.71	1.8	0.98	2.99	2.04	1.92	1.29	0.95
Price/Sales	- -	- -	17.68	26.5	19.32	16.08	52.52	253.61	51.53	74.61	19.91	14.4
Price/Sales Average	- -	- -	26.18	23.91	34.14	16.58	21.23	227.32	90.41	90.06	38.42	17.84
Price/Sales High	- -	- -	40.99	45.96	50.93	20.83	67.58	434.83	176.7	116.19	59.55	45.24
Price/Sales Low	- -	- -	16	14.93	15.61	11.25	8.86	94.07	48.32	55.46	19.37	9.45
Price/Cash Flow	- -	- -	8.07	-10.6	-9.6	-6.71	-61.02	-37.25	-8.06	-6.87	-3.3	-2.47
Price/Cash Flow Average	- -	- -	11.95	-9.57	-16.96	-6.92	-24.67	-33.39	-14.14	-8.29	-6.37	-3.06
Price/Cash Flow High	- -	- -	18.71	-18.39	-25.3	-8.7	-78.52	-63.87	-27.63	-10.7	-9.88	-7.76
Price/Cash Flow Low	- -	- -	7.3	-5.97	-7.76	-4.7	-10.3	-13.82	-7.56	-5.11	-3.21	-1.62
Price/Free Cash Flow Average	- -	- -	10.21	-11.32	-18.92	-7.41	-26.58	-35.4	-17.14	-8.59	-6.48	-3.07
Price/Free Cash Flow High	- -	- -	15.98	-21.75	-28.23	-9.31	-84.6	-67.71	-33.5	-11.09	-10.05	-7.78
Price/Free Cash Flow Low	- -	- -	6.24	-7.07	-8.65	-5.03	-11.09	-14.65	-9.16	-5.29	-3.27	-1.62
EV/Sales Average	- -	- -	9.61	10.87	32.2	15.67	19.15	225.82	82.88	86.99	38.78	16.92
EV/Sales High	- -	- -	24.42	32.92	49	19.93	65.5	433.33	169.16	113.12	59.92	44.32
EV/Sales Low	- -	- -	- -	1.89	13.68	10.35	6.78	92.58	40.78	52.39	19.73	8.53
EV/EBITDA Average	- -	5.8	-5.1	-4.26	-11.34	-6.7	-8.52	-28.6	-9.59	-6.23	-4.28	-2.69
EV/EBITDA High	- -	5.8	-12.96	-12.92	-17.26	-8.52	-29.16	-54.89	-19.57	-8.1	-6.62	-7.06
EV/EBITDA Low	- -	5.8	0.3	-0.74	-4.82	-4.42	-3.02	-11.73	-4.72	-3.75	-2.18	-1.36
EV/EBIT Average	- -	5.65	-4.92	-4.08	-10.79	-6.35	-8.13	-27.87	-9.43	-6.12	-4.2	-2.6
EV/EBIT High	- -	5.65	-12.52	-12.36	-16.41	-8.07	-27.81	-53.47	-19.24	-7.96	-6.49	-6.8
EV/EBIT Low	- -	5.65	0.29	-0.71	-4.58	-4.19	-2.88	-11.42	-4.64	-3.69	-2.14	-1.31
Last Price	- -	- -	13.11	19.22	13.65	14.67	54.4	118.24	34.89	30.49	11.66	8.99
High Price	- -	- -	30.4	33.34	35.99	19	70	202.73	119.65	47.48	34.87	28.25
Enterprise Value Average	7	-76	158	284	980	676	1,111	7,464	4,320	3,156	2,245	1,145
Enterprise Value High	7	-76	402	860	1,491	859	3,798	14,323	8,817	4,103	3,468	2,999
Enterprise Value Low	7	-76	-9	49	416	446	393	3,060	2,126	1,901	1,142	577

Shares Outstanding	34	34	36	42	44	50	66	74	87	93	102	116
Diluted Weighted Avg Shares	- -	18	22	36	43	47	56	71	77	89	99	108
Basic Weighted Avg Shares	- -	18	22	36	43	47	56	71	77	89	99	108
Revenue per Share	- -	0.34	0.74	0.73	0.71	0.91	1.04	0.47	0.68	0.41	0.59	0.62
EBITDA per Share	- -	-0.74	-1.4	-1.85	-2.01	-2.13	-2.33	-3.68	-5.85	-5.7	-5.3	-3.92
Operating Income per Share	- -	-0.76	-1.45	-1.93	-2.11	-2.25	-2.44	-3.78	-5.95	-5.8	-5.4	-4.07
Basic EPS, GAAP	- -	-0.7	-1.42	-1.88	-1.98	-2.11	-2.4	-3.78	-6.16	-5.42	-5.25	-3.81
Basic EPS from Cont Ops	- -	-0.7	-1.42	-1.88	-1.98	-2.11	-2.4	-3.78	-6.16	-5.42	-5.25	-3.81
Diluted EPS, GAAP	- -	-0.7	-1.42	-1.88	-1.98	-2.11	-2.4	-3.78	-6.16	-5.42	-5.25	-3.81
Diluted EPS from Cont Ops	- -	-0.7	-1.42	-1.88	-1.98	-2.11	-2.4	-3.78	-6.16	-5.42	-5.25	-3.81
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.1	1.62	-1.81	-1.42	-2.19	-0.89	-3.17	-4.33	-4.44	-3.53	-3.64
Free Cash Flow per Basic Share	- -	-0.24	1.35	-2.09	-1.57	-2.33	-0.96	-3.35	-5.09	-4.6	-3.59	-3.65
Cash & Equivalents per Share	- -	4.29	12.29	9.46	7.29	5.92	10.67	10.56	15.49	10.28	6.09	4.15
Book Value per Share	- -	-1.24	-2.41	-3.36	-4.67	-6.37	-7.77	-9.92	-15.29	-18.68	-22.03	-23.9
Tangible Book Value per Share	- -	-1.2	9.44	8.35	6.45	5.71	9.41	14.67	16.05	11.83	8.82	6.2

Intellia Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)